GlobalGov › Germany › Solicitation

Germany – Architectural, construction, engineering and inspection services – Expert assessment of radiation protection

Original title (Hungarian): Germany – Architectural, construction, engineering and inspection services – Sachverständigenprüfung Strahlenschutz

Health · Germany government procurement

Closed February 26, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Im Rahmen der Realisierung des Bauvorhabens "Neubau der Krankenversorgung der MHH am Stadtfelddamm Baustufe 1 - KVBS1" sind eine technische Begleitung und Sachverständigenleistungen für den Bereich Strahlenschutz erforderlich.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryResearch and Studies
PublishedJanuary 16, 2026
Procurement stageActive solicitation
ClosedFebruary 26, 2026
StatusClosed — no longer accepting responses
TranslationTranslated from Hungarian by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Browse all categories →

Browse Similar Open Opportunities in Germany

Germany – Technical testing, analysis and consultancy services – Abschluss eines nicht-exclusiven Rahmenvertrages Bauwerksprüfungen nach DIN 1076 im Open-House-Verfahren der NL Rheinland, veröffentlicht 2023
Germany – Architectural, engineering and surveying services – Conclusion of a non-exclusive framework agreement for surveying services in an open-house procedure of the Southern Bavaria branch, published 2023
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Thalidomid, ATC L04AX02 (OBG) für die Zeit 01.11.2024 - 31.10.2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Formoterol/Glycopyrronium/Budesonid (ATC-Code nach WHO: R03AL11)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Guanfacin, ATC N06BA21
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient iron carboxymaltose (ATC code: B03AC01).
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Risperidon (ATC-Code N05AX08) eingeschränkt auf die Darreichung Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension.

See every Germany Research and Studies opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Research and Studies intelligence report in your inbox

A personalized report on Germany Research and Studies opportunities, emailed in 5-10 minutes. One per month, no account needed.